Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels.
Fajardo-Robledo NS, Jacobo-Cuevas H, Perez-Guerrero EE, Corona-Sanchez EG, Saldaña-Cruz AM, Romero-Tejeda EM, Rodriguez-Jimenez NA, Totsuka-Sutto SE, Lopez-Roa RI, Ponce-Guarneros JM, Alcaraz-Lopez MF, Cerpa-Cruz S, Muñoz-Valle JF, Cardona-Muñoz EG, Gonzalez-Lopez L, Gamez-Nava JI; Research Group for Factors Related to Therapeutic Outcomes in Autoimmune Diseases.
Fajardo-Robledo NS, et al.
Sci Rep. 2022 Feb 3;12(1):1877. doi: 10.1038/s41598-022-05644-7.
Sci Rep. 2022.
PMID: 35115601
Free PMC article.